Impact of Adenotonsillectomy on Quality of Life in Pediatric Obstructive Sleep Apnoea (OSA): Insights from the OSA-18 Questionnaire.

IF 3.4 2区医学 Q2 CLINICAL NEUROLOGY

Nature and Science of Sleep Pub Date : 2025-06-12 eCollection Date: 2025-01-01 DOI:10.2147/NSS.S506720

Montaha Al-Iede, Zaina Alhelou, Nour Hamdan, Basil Alramahi, Shada Algharibeh, Ahmad Qarajeh, Sara Ishtaieh, Ahmad Al Nsour, Mai AlAdwan, Abdulrahman Alhanbali, Rima A Sinan, Lubna Khreesha

{"title":"Impact of Adenotonsillectomy on Quality of Life in Pediatric Obstructive Sleep Apnoea (OSA): Insights from the OSA-18 Questionnaire.","authors":"Montaha Al-Iede, Zaina Alhelou, Nour Hamdan, Basil Alramahi, Shada Algharibeh, Ahmad Qarajeh, Sara Ishtaieh, Ahmad Al Nsour, Mai AlAdwan, Abdulrahman Alhanbali, Rima A Sinan, Lubna Khreesha","doi":"10.2147/NSS.S506720","DOIUrl":null,"url":null,"abstract":"Purpose: Hypertrophy of the adenoids and tonsils is a common cause of obstructive sleep apnoea (OSA) in children, with adenotonsillectomy as the primary treatment. This study aimed to assess the efficacy of surgical options (adenotonsillectomy, adenoidectomy, and tonsillectomy) in managing pediatric OSA and their impact on quality of life, using the OSA-18 questionnaire.Methods: This retrospective cohort study analyzed data from parents of 196 children who underwent adenoidectomy, tonsillectomy, or both. The OSA-18 questionnaire was administered online via Google Form to assess quality-of-life issues. Data collection occurred between November 4 and December 25, 2022. Statistical analysis included paired t-tests, ANOVA, Pearson's correlation, and stepwise linear regression to evaluate pre- and post-surgery differences and associated factors.Results: A significant improvement in quality of life was observed following adenotonsillectomy, with a mean reduction of 15.14 points in OSA-18 scores. The greatest improvements were noted in the domains of physical symptoms and sleep disturbance, particularly among children with severe OSA. Most participants were male (63%), with an average pre-surgery weight of 25.5 kg. Prior to surgery, 34.18% used CPAP and 56.12% nasal steroids. Post-surgery, 83.16% were hospitalized for 1-2 days, with 4.08% requiring ICU care, and 26.53% experienced postoperative complications.Conclusion: Surgical interventions, particularly adenotonsillectomy, significantly improved quality of life in pediatric OSA patients, with marked benefits in severe cases.","PeriodicalId":18896,"journal":{"name":"Nature and Science of Sleep","volume":"17 ","pages":"1291-1301"},"PeriodicalIF":3.4000,"publicationDate":"2025-06-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12170811/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Nature and Science of Sleep","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.2147/NSS.S506720","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/1/1 0:00:00","PubModel":"eCollection","JCR":"Q2","JCRName":"CLINICAL NEUROLOGY","Score":null,"Total":0}

引用次数: 0

Abstract

Purpose: Hypertrophy of the adenoids and tonsils is a common cause of obstructive sleep apnoea (OSA) in children, with adenotonsillectomy as the primary treatment. This study aimed to assess the efficacy of surgical options (adenotonsillectomy, adenoidectomy, and tonsillectomy) in managing pediatric OSA and their impact on quality of life, using the OSA-18 questionnaire.

Methods: This retrospective cohort study analyzed data from parents of 196 children who underwent adenoidectomy, tonsillectomy, or both. The OSA-18 questionnaire was administered online via Google Form to assess quality-of-life issues. Data collection occurred between November 4 and December 25, 2022. Statistical analysis included paired t-tests, ANOVA, Pearson's correlation, and stepwise linear regression to evaluate pre- and post-surgery differences and associated factors.

Results: A significant improvement in quality of life was observed following adenotonsillectomy, with a mean reduction of 15.14 points in OSA-18 scores. The greatest improvements were noted in the domains of physical symptoms and sleep disturbance, particularly among children with severe OSA. Most participants were male (63%), with an average pre-surgery weight of 25.5 kg. Prior to surgery, 34.18% used CPAP and 56.12% nasal steroids. Post-surgery, 83.16% were hospitalized for 1-2 days, with 4.08% requiring ICU care, and 26.53% experienced postoperative complications.

Conclusion: Surgical interventions, particularly adenotonsillectomy, significantly improved quality of life in pediatric OSA patients, with marked benefits in severe cases.

Abstract Image

查看原文本刊更多论文

腺扁桃体切除术对儿童阻塞性睡眠呼吸暂停（OSA）患者生活质量的影响：来自OSA-18问卷的见解

目的：腺样体和扁桃体肥大是儿童阻塞性睡眠呼吸暂停（OSA）的常见原因，腺样体切除术是主要治疗方法。本研究旨在评估手术选择（腺扁桃体切除术、腺样体切除术和扁桃体切除术）治疗儿童OSA的疗效及其对生活质量的影响，采用OSA-18问卷。方法：本回顾性队列研究分析了196名接受腺样体切除术、扁桃体切除术或两者兼有的儿童家长的资料。OSA-18问卷通过谷歌表格在线进行，以评估生活质量问题。数据收集时间为2022年11月4日至12月25日。统计分析包括配对t检验、方差分析、Pearson相关和逐步线性回归来评估术前和术后差异及相关因素。结果：腺扁桃体切除术后生活质量显著改善，OSA-18评分平均降低15.14分。最大的改善是在身体症状和睡眠障碍领域，特别是在患有严重呼吸暂停综合症的儿童中。大多数参与者为男性（63%），平均术前体重为25.5公斤。术前，34.18%的患者使用CPAP， 56.12%的患者使用鼻腔类固醇。术后住院1 ~ 2天占83.16%，需要ICU护理的占4.08%，出现术后并发症的占26.53%。结论：手术干预，特别是腺扁桃体切除术，可显著改善儿童OSA患者的生活质量，重症患者获益显著。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Nature and Science of Sleep Neuroscience-Behavioral Neuroscience

CiteScore

5.70

自引率

5.90%

发文量

245

审稿时长

16 weeks

期刊介绍： Nature and Science of Sleep is an international, peer-reviewed, open access journal covering all aspects of sleep science and sleep medicine, including the neurophysiology and functions of sleep, the genetics of sleep, sleep and society, biological rhythms, dreaming, sleep disorders and therapy, and strategies to optimize healthy sleep. Specific topics covered in the journal include: The functions of sleep in humans and other animals Physiological and neurophysiological changes with sleep The genetics of sleep and sleep differences The neurotransmitters, receptors and pathways involved in controlling both sleep and wakefulness Behavioral and pharmacological interventions aimed at improving sleep, and improving wakefulness Sleep changes with development and with age Sleep and reproduction (e.g., changes across the menstrual cycle, with pregnancy and menopause) The science and nature of dreams Sleep disorders Impact of sleep and sleep disorders on health, daytime function and quality of life Sleep problems secondary to clinical disorders Interaction of society with sleep (e.g., consequences of shift work, occupational health, public health) The microbiome and sleep Chronotherapy Impact of circadian rhythms on sleep, physiology, cognition and health Mechanisms controlling circadian rhythms, centrally and peripherally Impact of circadian rhythm disruptions (including night shift work, jet lag and social jet lag) on sleep, physiology, cognition and health Behavioral and pharmacological interventions aimed at reducing adverse effects of circadian-related sleep disruption Assessment of technologies and biomarkers for measuring sleep and/or circadian rhythms Epigenetic markers of sleep or circadian disruption.